Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report [Corrigendum]

Terao T, Ishida A, Kimura T, Yoshida M, Hara T. Neuropsychiatr Dis Treat. 2017;13:1441–1448.On page 1443, Results section, Patient disposition subheading, Figure S1, ‘Excluded from HAM-D analysis setC 69’ should have been ‘Excluded from HAM-D analysis setC 269...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Terao T, Ishida A, Kimura T, Yoshida M, Hara T
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/d12b18d138da44868132c01afdf4ec31
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Terao T, Ishida A, Kimura T, Yoshida M, Hara T. Neuropsychiatr Dis Treat. 2017;13:1441–1448.On page 1443, Results section, Patient disposition subheading, Figure S1, ‘Excluded from HAM-D analysis setC 69’ should have been ‘Excluded from HAM-D analysis setC 269’.Read the original article